MEDICAL INSTRUMENTS AND APPARATUS INDUSTRY – AUSTRALIA

ResMed falls 18pc as trial boosts patients’ risk of dying

roymorgansocial Leave a comment

Original article by Jessica Gardner
The Australian Financial Review – Page: 15 & 20 : 15-May-15

Wilson HTM has changed its recommendation on ResMed from "buy" to "sell" after clinical trials of a sleep apnoea device showed that patients with a heart condition were at greater risk of death when using it. The results of the clinical trial prompted ResMed’s Australian-listed shares to close $A1.52 lower at $A6.73 on 14 May 2015. ResMed notes that the ventilation machine used in the clinical trial accounted for just seven per cent of its revenue in the last financial year.

CORPORATES
RESMED INCORPORATED – ASX RMD, WILSON HTM INVESTMENT GROUP LIMITED – ASX WIG, CREDIT SUISSE (AUSTRALIA) LIMITED, DEUTSCHE BANK AG, UBS HOLDINGS PTY LTD

Perth toddler first person to get artificial pancreas

roymorgansocial Leave a comment

Original article by Aleisha Orr
The Age – Page: 10 : 22-Jan-15

A team at Princess Margaret Hospital for Children in Perth has fitted a newly developed medical device that functions as an artificial pancreas to a four-year-old boy suffering from type-1 diabetes. The battery-powered pump supplies insulin in doses according to automated readings of glucose levels, in order to prevent hypoglycaemic attacks. The product is already freely available to diabetes patients, including adults, but the cost is still high at $A10,000

CORPORATES
PRINCESS MARGARET HOSPITAL